WallStSmart

BGC Group Inc. (BGC)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 69836% more annual revenue ($2.17T vs $3.10B). NMR leads profitability with a 16.7% profit margin vs 5.9%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 70/100 (B-).

BGC

Buy

60

out of 100

Grade: C+

Growth: 9.3Profit: 5.5Value: 3.7Quality: 4.5
Piotroski: 4/9Altman Z: 1.34

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BGC2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
44.3%10/10

Revenue surging 44.3% year-over-year

EPS GrowthGrowth
54.8%10/10

Earnings expanding 54.8% YoY

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

BGC4 concerns · Avg: 3.0/10
P/E RatioValuation
32.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
5.9%3/10

5.9% margin — thin

Debt/EquityHealth
1.623/10

Elevated debt levels

PEG RatioValuation
3.602/10

Expensive relative to growth rate

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : BGC

The strongest argument for BGC centers on Revenue Growth, EPS Growth. Revenue growth of 44.3% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : BGC

The primary concerns for BGC are P/E Ratio, Profit Margin, Debt/Equity. Debt-to-equity of 1.62 is elevated, increasing financial risk.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

BGC profiles as a hypergrowth stock while NMR is a growth play — different risk/reward profiles.

BGC carries more volatility with a beta of 0.95 — expect wider price swings.

BGC is growing revenue faster at 44.3% — sustainability is the question.

BGC generates stronger free cash flow (-26M), providing more financial flexibility.

Bottom Line

NMR scores higher overall (70/100 vs 60/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BGC Group Inc.

FINANCIAL SERVICES · CAPITAL MARKETS · USA

BGC Group Inc. (BGC) is a leading global brokerage and financial technology firm, specializing in fixed income, foreign exchange, and derivatives markets. With a strong emphasis on inter-dealer broking, BGC leverages cutting-edge technology to provide innovative solutions that enhance liquidity for a diverse clientele, including financial institutions, hedge funds, and corporations. Its commitment to operational excellence and sustainable growth strategically positions BGC as a market leader, offering institutional investors a compelling opportunity to engage with a forward-thinking player in the evolving financial services sector.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?